Andreas Kuhn
9Patents
3h-index
28Co-inventors
53Inventor score
Filing activity: Aug 3, 2010 → Nov 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10717982B2 | Stabilization of poly(A) sequence encoding DNA sequences | Chemistry; Metallurgy | 12 | Active |
| US9295717B2 | Vaccine composition comprising 5′-cap modified RNA | Human Necessities | 11 | Active |
| US11547673B1 | Coronavirus vaccine | Emerging Cross-Sectional Technologies | 8 | Active |
| US11925694B2 | Coronavirus vaccine | Emerging Cross-Sectional Technologies | 1 | Active |
| US12054723B2 | Stabilization of poly(A) sequence encoding DNA sequences | Chemistry; Metallurgy | 0 | Active |
| US12281138B2 | 5′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapy | Human Necessities | 0 | Active |
| US12305210B2 | In vitro transcription technologies | Chemistry; Metallurgy | 0 | Active |
| US12133899B2 | Coronavirus vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
| US11492628B2 | 3′-UTR sequences for stabilization of RNA | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.